Rapid Micro Biosystems Inc Cl A (RPID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,030 | 16,911 | 24,285 | 27,064 | 178,387 |
| Marketable Securities | 18,266 | 33,821 | 67,768 | 81,584 | 15,110 |
| Receivables | 3,134 | 7,519 | 5,532 | 5,369 | 5,005 |
| Inventories | 17,593 | 20,200 | 19,961 | 21,187 | 15,671 |
| TOTAL | $61,168 | $80,917 | $120,415 | $138,576 | $218,124 |
| Non-Current Assets | |||||
| PPE Net | 8,972 | 11,193 | 12,832 | 13,818 | 11,304 |
| Investments And Advances | 0 | 0 | 2,911 | 29,790 | 9,966 |
| Other Non-Current Assets | 4,712 | 6,059 | 7,294 | 8,466 | 1,775 |
| TOTAL | $13,684 | $17,252 | $23,037 | $52,074 | $23,045 |
| Total Assets | $74,852 | $98,169 | $143,452 | $190,650 | $241,169 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,139 | 2,535 | 1,973 | 5,428 | 3,944 |
| Accrued Expenses | 8,316 | 7,217 | 9,907 | 8,150 | 10,917 |
| TOTAL | $18,487 | $17,565 | $18,986 | $19,050 | $18,166 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,902 | 0 | N/A | N/A | N/A |
| Deferred Revenues | 4,734 | 6,599 | 5,974 | 4,706 | 3,305 |
| Other Non-Current Liabilities | 4,257 | 5,252 | 6,477 | 7,431 | 2,023 |
| TOTAL | $23,159 | $5,252 | $6,477 | $7,431 | $2,023 |
| Total Liabilities | $41,646 | $22,817 | $25,463 | $26,481 | $20,189 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,463 | 43,237 | 42,497 | 42,188 | 41,940 |
| Common Shares | 445 | 430 | 424 | 421 | 415 |
| Retained earnings | -522,397 | -475,274 | -428,385 | -375,918 | -315,112 |
| Other shareholders' equity | 11 | 39 | -101 | -1,109 | -16 |
| TOTAL | $33,206 | $75,352 | $117,989 | $164,169 | $220,980 |
| Total Liabilities And Equity | $74,852 | $98,169 | $143,452 | $190,650 | $241,169 |